1. Introduction {#sec1}
===============

Norepinephrine (NE) is a biogenic amine that has been associated with central functions such as attention, wakefulness, and the response to stress ([@bib62]; [@bib66]; [@bib67], [@bib68]). The locus coeruleus (LC) is the largest cluster of NE neurons in the brain that projects to almost all levels of the neuraxis and is the primary provider of NE to the prefrontal cortex (PFC) and hippocampus ([@bib11]). Importantly, the LC has been implicated in a number of stress-related psychiatric disorders such as anxiety and depression, as well as neurodegenerative diseases such as Alzheimer\'s Disease (AD). A critical area of future research, and an endpoint of the present study, is to determine the consequences of NE depletion on neurotransmitter systems that may be potential therapeutic targets for the treatment of chronic stress-related psychiatric and neurodegenerative disorders, such as the endogenous cannabinoid (eCB) system ([@bib14]; [@bib99]). This avenue of exploration is critical because damage to the LC, evident in animal models of depression, chronic stress ([@bib64]; [@bib52]; [@bib38]; [@bib53]; [@bib90]) and AD ([@bib95]; [@bib13]; [@bib32]; [@bib109]; [@bib21]; [@bib91]), and resultant alterations in NE transmission and signaling ([@bib106]; [@bib84]; [@bib82]; [@bib22]; [@bib110]; [@bib54]; [@bib86]; [@bib105]; [@bib74]; [@bib65]; [@bib61]) may be mitigated by targeting the eCB system ([@bib49]; [@bib36]; [@bib73]; [@bib103]; [@bib104]; [@bib5]; [@bib20]; [@bib26]; [@bib55]; [@bib46]; [@bib85]; [@bib15]). The purpose of the present study is to understand how the eCB system may undergo concurrent alterations in response to decreased NE transmission and, to further our current understanding of how the eCB system may be targeted to treat conditions in which the LC-NE system is disrupted.

Derived from plasma membrane phospholipids, endogenous cannabinoids (eCBs) are widely distributed throughout the central nervous system ([@bib33]; [@bib72]; [@bib23]). The first eCB ligand discovered was N-arachidonylethanolamide (AEA)([@bib29]), a compound synthesized by N-acyl-phosphatidylethanolamine (NAPE-PLD) ([@bib31]), and degraded by fatty acid amide hydrolase (FAAH) ([@bib28]). The most abundant eCB in the mammalian brain is 2-arachidonoylglycerol (2-AG) ([@bib59]; [@bib89]; [@bib87]), which is synthesized in postsynaptic neurons by diacylglycerol lipase (DGL) ([@bib12]) and degraded by monoacylglycerol lipase (MGL) ([@bib51]). The primary mechanism proposed for 2-AG release involves a depolarization or G protein-induced 2-AG postsynaptic synthesis, followed by retrograde signaling and binding of the endogenous ligand to presynaptically distributed cannabinoid type 1 (CB1r) ([@bib33]; [@bib23]; [@bib16],[@bib17]; [@bib18]). Although extensive literature supports modulation of glutamate and GABA transmission by cannabinoids, growing evidence supports their action on catecholamines, including NE.

We, among others, have previously shown that CB1r are abundantly expressed in NE- LC neurons, and may serve as a cellular substrate for modulating LC activity ([@bib66]; [@bib67], [@bib68]; [@bib16],[@bib17]). We have also provided anatomical evidence for direct synaptic associations between NE afferents in the PFC, CB1r and DGL, using high-resolution immunoelectron microscopy. DGL-α, the most abundant isoform of DGL, is localized in postsynaptic neurons that are targeted by axon terminals immunoreactive for dopamine β-hydroxylase (DβH) ([@bib75]). DβH converts dopamine to NE and represents a marker for NE neurons, as it completes the final step of NE synthesis and is present in the vesicles of NE axon terminals ([@bib42]). CB1r and DβH are co-localized presynaptically ([@bib66]; [@bib75]), suggesting regulation of the NE afferents by the eCB system in the PFC ([@bib75]).

The eCB system modulates NE signaling primarily through CB1r ([@bib16],[@bib17]), both in the LC and in the PFC. Several previously published studies from our group and others provide evidence for a functional link between CB1r and NE output. For example, repeated administration of the CB1r agonist WIN 55,212--2 results in increased tyrosine hydroxylase (TH) expression in the LC ([@bib67]), the enzyme responsible for the first and rate-limiting step of NE biosynthesis ([@bib63]). Further, alterations in TH expression were accompanied by increases in anxiety-like behavior ([@bib67]). Moreover, administration of WIN 55,212--2 results in two-fold increases in NE efflux in the PFC, an effect that is abrogated by pretreatment with the CB1r selective antagonist SR-141716 A ([@bib66]; [@bib67], [@bib68]). The link between chronic cannabis use and affective disorders including anxiety, depression, cognitive impairment and psychosis is supported by several studies ([@bib1]; [@bib27]; [@bib10]; [@bib70]; [@bib57]). Of particular relevance, is the finding that chronic exposure to cannabinoid agonists is associated with mood disorders including anxiety and depression ([@bib26]; [@bib69]; [@bib102]), which may be, in part, an effect driven by its influence on NE.

With mounting evidence that the eCB system has profound modulatory effects on the LC-NE system, we sought to determine the effects of NE depletion on the eCB system. To accomplish this, in the present study we have employed two approaches to induce noradrenergic depletion. First, we used a genetically modified mouse model in which the DβH gene is knocked out (DβH-KO) ([@bib94]; [@bib93]). Second, we used a toxicological lesion caused by intraperitoneal injection of the LC-selective neurotoxin, N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP-4) ([@bib47]) a model that has been used to recapitulate conditions of LC-specific degeneration ([@bib44]; [@bib48]). The level of eCB tone, and consequent activity, is influenced by the balance of eCB synthesizing and degrading enzymes. To explore the protein expression of the 2-AG synthesizing and degrading enzymes under the conditions of NE depletion, DGL-α, MGL and FAAH were examined in the prefrontal cortex by Western blot analysis. These findings provide additional information for further understanding the complex interaction of eCB- and NE systems in neurological and psychiatric disorders by demonstrating that significant sex differences exist in eCB compensation in response to NE depletion.

2. Materials and methods {#sec2}
========================

The procedures employed in the present study conformed to Drexel University Institutional Animal Care and Use Committee, *National Institute of Health\'s Guide for the Care and Use of Laboratory Animals* (1996), the Health Research Extension Act (1985) and the PHS Policy on Humane Care and Use of Laboratory Animals (1986). All efforts were made to utilize only the minimum number of animals necessary to produce reliable scientific data, and experiments were designed to minimize any animal distress.

2.1. DβH-KO mice and DSP-4 administration in rats {#sec2.1}
-------------------------------------------------

For Western blotting experiments, wild-type (WT) and DβH-KO littermates (3--8 months old) were housed three per cage in a controlled environment (12-h light schedule, temperature at 20 °C). In this study, there were a total of 30 mice used, 9 male WT mice, 9 male DβH-KO mice, 6 female WT mice, and 6 female DβH-KO mice. The DβH-KO mice were genetically engineered to disrupt the allele coding for DβH; therefore, these mice do not produce DβH and cannot synthesize NE ([@bib94]; [@bib93]). L-dihydroxyphenylserine (L-DOPS), a synthetic precursor to NE, was administered during embryonic development (E8.5-E19) in the pregnant female\'s drinking water because NE is essential to the survival of the fetus ([@bib94]). WT and DβH-KO mice were anesthetized with isoflurane (Vedco, St. Joseph, MO), then decapitated for brain extraction and microdissection.

For Western blot experiments, 14 adult male and 10 adult female Sprague-Dawley rats (Jackson Laboratory) weighing 200--250 g were used to examine the effects of DSP-4 (Sigma-Aldrich, St. Louis, MO) injections on protein expression. All rats were housed two per cage in a controlled environment (12-h light schedule, temperature at 20 °C). After a one-week acclimation period, the rats were weighed and injected intraperitoneally with 0.9% saline (females n = 4, males n = 6) or 50 mg/kg of DSP-4 in 0.9% saline (females n = 3, males n = 5) (Sigma-Aldrich, St Louis, MO). After seven days, all rats were anesthetized with isoflurane, then decapitated for brain extraction.

2.2. Analysis of estrous cycle {#sec2.2}
------------------------------

Female naïve rats used in baseline studies were monitored for hormonal (estrous) cycle by daily vaginal smear. Phases of estrous cycles were determined as previously described ([@bib25]; [@bib121]). It was determined that all 3 female rats used in baseline experiments were in proestrous.

2.3. Protein extraction and western blot analysis {#sec2.3}
-------------------------------------------------

Brain tissues from the mice and rats were rapidly removed from each animal and placed on ice. Using a trephine, the medial PFC brain region was microdissected from each animal. The PFC was homogenized with a pestle and extracted in radioimmunoprecipitation assay (RIPA) lysis buffer (Santa Cruz Biotechnology, Santa Cruz, CA) on ice for 20 min. Lysates were cleared by centrifugation at 13,000 rpm for 12 min at 4 °C. Supernatants or protein extracts were diluted with an equal volume of Novex 2^®^ tris glycine sodium dodecyl sulfate sample buffer (Invitrogen, Carlsbad, CA) containing dithiothreitol (Sigma-Aldrich Inc., St. Louis, MO). Protein concentrations of the undiluted supernatants were quantified using the bicinchoninic acid protein assay reagent (Pierce, Rockford, IL).

Cell lysates containing equal amounts of protein were separated on 4--12% tris-glycine polyacrylamide gels and then electrophoretically transferred to Immobilon-P polyvinylidene fluoride membranes (Millipore, Bedford, MA). Membranes containing proteins from the medial PFC were incubated in anti-rabbit DGL-α (1:500 ([@bib50]);) and mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:2000; ProteinTech, Rosemont, IL, USA) primary antibodies overnight at 4 °C and then in IRdye 800CW goat anti-rabbit antibody at 1:15000 (Li-COR, Inc. Lincoln, NE, USA; P/N 926--32213) and IRdye 680LT goat anti-mouse antibody at 1:20000 (Li-COR, Inc. Lincoln, NE, USA; P/N 925--68020) for 60 min to probe for the presence of proteins. Following incubation in the secondary antibodies, blots were exposed to the Odyssey instrument (Li-COR, Inc. Lincoln, NE). DGL-α was readily detected by immunoblotting in mouse and rat PFC extracts, and was visualized as a single band that migrates at approximately 150 kDa and GAPDH as a single band that migrates at approximately 37 kDa. Blots were incubated in stripping buffer (Restore Stripping Buffer, Pierce) to disrupt previous antibody-antigen interactions and incubated in rabbit MGL (1:200 ([@bib88]);) and rabbit FAAH (1:200 ([@bib43]);) primary antibodies overnight at room temperature and then in IRdye 800CW goat anti-rabbit antibody at 1:15000 (Li-COR, Inc. Lincoln, NE, USA; P/N 926--32213) for 60 min to probe for the presence of proteins. Following incubation in the secondary antibodies, blots were exposed to the Odyssey instrument (Li-COR, Inc. Lincoln, NE). MGL was readily detected by immunoblotting in mouse and rat PFC extracts, and was visualized as a single band that migrates at approximately 33 kDa and FAAH as a single band that migrates at approximately 63 kDa. Primary antibodies for MGL and FAAH were provided by Dr. Mackie.

2.4. Enzyme-Linked Immuno-Sorbent Assay (ELISA) {#sec2.4}
-----------------------------------------------

Sandwich ELISA was conducted in accordance with the instructions provided in the NE kit (NOU39-K010; Eagle, Nashua, NH). Cell lysates from 6 male and 6 female rats treated with saline or DSP-4 containing equal amounts of protein (20 μg) were used. Each sample was run in technical triplicate. A standard curve was run for each replicate and was used to estimate the concentration of NE in each sample.

2.5. Quantification {#sec2.5}
-------------------

Using Image Studio Software (Li-COR, Inc. Lincoln, NE, USA), DGL-α, MGL and FAAH immunoreactivity was normalized to GAPDH immunoreactivity on each respective blot. Two-way ANOVA was used to analyze the difference in DGL-α, MGL or FAAH protein expression between WT and DβH-KO mice and male and female mice as well as in saline or DSP-treated male and female rats. All statistical analysis tests were performed using GraphPad Prism 7.03 Software (GraphPad Software, Inc. La Jolla, CA).

2.6. Tissue preparation {#sec2.6}
-----------------------

Male rats used for immunohistochemistry (IHC) were deeply anesthetized using isoflurane (Vedco, St. Joseph, MO) and subsequently transcardially perfused through the ascending aorta with the following fixatives: 10 ml of 1000 units/ml heparinized saline, 50 ml of 3.75% acrolein in 2% formaldehyde and 200 ml of 2% formaldehyde in 0.1 M phosphate buffer (PB) pH 7.4. Sections from the acrolein-fixed cases (n = 5) were used for immunoelectron microscopy, as acrolein fixation yields optimal tissue preservation for ultrastructural analysis. For immunofluorescence microscopy, the same procedure was conducted with 4% formaldehyde in 0.1 M PB without acrolein (n = 5). The brains were removed, cut into 4--5 mm coronal blocks, stored in 2% paraformaldehyde fixative for an additional 30 min and then sectioned (30--40 μm) on a vibrating microtome (Vibratome; Pelco EasiSlicer, Ted Pella, Redding, CA) for electron microscopy, or a cryostat (Microm HM 50, Microm International, Waldorf, Germany) for fluorescence microscopy. Brains were cut in 40 μm coronal sections, and PFC sections were selected for IHC processing using the rat brain atlas of Paxinos and Watson ([@bib119]). The medial PFC was the primary region of interest selected for immunohistochemistry experiments and is imaged in the micrographs displayed in [Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"}.

2.7. Immunohistochemical labeling {#sec2.7}
---------------------------------

### 2.7.1. Primary antisera {#sec2.7.1}

Acrolein-perfused tissues were incubated in 1% sodium borohydride in 0.1 M PB to remove reactive aldehydes, and then blocked in 0.5% BSA in 0.1 M Tris-buffered saline (TBS). Tissue sections were incubated for 48 h at 4 °C in primary antibody in 0.1% BSA and 0.25% Triton X-100 in 0.1 M TBS. Triple-labeled tissues were incubated in a cocktail of rabbit anti-MGL (1:200) or rabbit anti-FAAH (1:200), guinea pig anti-CB1 (1:1000) and mouse anti-DβH (Chemicon International, Temecula, CA; 1:1000) or mouse anti-NET (MAb Technologies Inc., Stone Mountain, GA; 1:1000 (for specificity and characterization, see ([@bib66]; [@bib75]; [@bib83]).

### 2.7.2. Electron microscopy {#sec2.7.2}

The secondary antibodies used for electron microscopy were biotinylated anti-mouse for DβH at 1:400, and 1 nm gold particle conjugated goat anti-rabbit IgG (Electron Microscopy Science, Hatfield, PA) at 1:50 for MGL or FAAH. Immunoperoxidase labeling of DβH was performed as described above. Electron-dense labeling of MGL or FAAH was detected via silver intensification of immunogold particles using a silver enhancement kit (Aurion R-GENT SE-EM kit, Electron Microscopy Science). Tissues were prepared for visualization under the electron microscope as previously described, with osmification, serial dehydration, flat-embedding, and tissue sectioning at 74 nm on an ultramicrotome ([@bib24]). Sections were collected on copper mesh grids and examined using an electron microscope (Morgani, Fei Company, Hillsboro, OR). Digital images were viewed and captured using the AMT advantage HR HR-B CCD camera system (Advance Microscopy Techniques, Danvers, MA). Immunofluorescence and electron micrograph images were prepared using Adobe Photoshop to adjust the brightness and contrast.

### 2.7.3. Immunofluorescence {#sec2.7.3}

For confocal microscopy, detection of immunofluorescence-labeled antigens utilized two combinations of secondary antibodies. The first combination included secondary antibodies that were fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG (1:200; Jackson Immunoresearch) for MGL or FAAH detection; tetramethylrhodamine-5-isothiocyanate (TRITC)-conjugated donkey anti-guinea pig IgG (1:200; Jackson Immunoresearch) for CB1 detection and Cy5-conjugated donkey anti-mouse IgG (1:200; Jackson Immunoresearch) for DβH or NET detection. Tissue sections underwent serial dehydration, were mounted on slides, and coverslipped using DPX (Aldrich). Slides were then viewed using an Olympus IX81 inverted confocal microscope (Hatagaya, Shibuya-Ku, Tokyo, Japan), with helium and argon laser excitation wavelengths of 488, 543 and 635. The microscope is also equipped with filters (DM 405--44, BA505-605, and BA 560--660) and the Olympus Fluoview ASW FV1000 program. Fluorescence confocal images were assembled and adjusted for brightness and contrast in Adobe Photoshop.

2.8. Controls {#sec2.8}
-------------

Prior to dual and triple IHC experiments, antibodies were optimized using immunoperoxidase staining and light microscopy under a variety of experimental conditions including perfusion reagents (formaldehyde or acrolein), a series of antibody dilutions, and incubation period (overnight at room temperature or 48 h at 4 °C). In addition to negative control groups that do not contain primary antibody, control groups containing primary, but no secondary were used to reveal any endogenous fluorescence or peroxidase activity. Common pitfalls of IHC have been well described ([@bib34]), and have been addressed in these optimization studies. Following fixation and primary antibody incubation under the optimal conditions determined for each antibody, the tissues were subject to immunoperoxidase labeling techniques as previously described ([@bib100]). Tissues were dehydrated in a series of escalating alcohol concentrations and coverslipped with Permount (Fischer, Hampton, NH) for viewing on a light microscope (Olympus BX51, Japan, D10BXF Camera, Diagnostic Instruments, USA), or coverslipped with DPX for viewing on a confocal microscope (Olympus).

To ensure specificity of the biotinylated and gold-conjugated secondary antibodies for quantification at the ultrastructural level, control tissue taken directly from the plastic-tissue interface was processed in parallel, with omission of the primary antisera for MGL, FAAH, CB1r and DβH, and was devoid of immunolabeling. Single spurious immunogold-silver labeling may contribute to false positive labeling, indicated by the presence of single immunogold-silver particles on blood vessels, myelin or nuclei ([@bib76]; [@bib100]). To estimate the extent of spurious labeling, a randomized sampling of 100 myelin processes was evaluated for immunogold labeling; while spurious single gold particles were present, there was minimal labeling for 2 or more gold particles (1/100), thus a criterion of 2 or more gold particles was upheld for quantification purposes.

2.9. Ultrastructural analysis {#sec2.9}
-----------------------------

Quantification and analysis of MGL or FAAH and DβH localization at the EM level were conducted as previously reported ([@bib24]; [@bib66]). Adequate preservation of ultrastructural morphology was one of the criteria imposed when selecting tissue sections to be used for ultrastructural analysis. A minimum of 3 sections per region of each animal from 6 animals were used for the analysis. At least 10 grids containing 4--7 thin sections each were collected from plastic-embedded sections of the PFC from each animal. Quantitative evaluation of immunoreactive elements was applied only to the outer 1--3 μm of the epon--tissue interface where penetration of antisera is optimal. To prevent the inclusion of spurious labeling in quantification, only profiles with a minimum of 2 gold particles were considered immunoreactive and used for quantification. For dual labeling, only micrographs containing both peroxidase and gold--silver markers were used for the tissue analysis to ensure that the absence of one marker did not result from uneven penetration of markers ([@bib116]). Examination of serial sections was used to determine synaptic associations of axon terminals not always apparent in single sections.

Cellular elements were isolated and classified based on Fine Structure of the Nervous System ([@bib71]). Somata were identified by the presence of a nucleus, Golgi apparatus, and smooth endoplasmic reticulum. Proximal dendrites contained endoplasmic reticulum, were apposed to axon terminals, and were larger than 0.7 μm in diameter. Synapses were verified by the presence of a junctional complex, a restricted zone of parallel membranes with slight enlargement of the intercellular space, and/or associated postsynaptic thickening. A synaptic specialization was only designated to the profiles that form clear morphological characteristics of either Type I or Type II ([@bib39]). Asymmetric synapses were identified by thick postsynaptic densities (Gray\'s Type I; [@bib39]), while symmetric synapses had thin densities both pre- and postsynaptically (Gray\'s Type II; [@bib39]). An undefined synapse was defined as an axon terminal plasma membrane juxtaposed to a dendrite or soma devoid of recognizable membrane specializations and no intervening glial processes. Axon terminals were distinguished from unmyelinated axons based on synaptic vesicle presence and a diameter of greater than 0.1 μm.

Data from 6 (n = 3 male, n = 3 female) animals were used in the characterization of the anatomical substrate for eCB-NE interactions. For each animal, comparable levels of the medial PFC were selected for ultra-thin sectioning. For each animal, dendritic and axon-terminal profiles were sampled from at least 5 copper grids of ultrathin tissue sections near the tissue-plastic interface. Approximately 500 profiles from each animal were scanned, and approximately 300 of these fit all criteria below and were included in the analysis. Dendrites with a maximal cross-sectional diameter between 0.7 μm and 5 μm met the criteria for analysis, and a mix of dendrites of sizes from across this range was included in the analysis. Large profiles were excluded to avoid the bias towards positive labeling of larger structures. Extremely small, large, longitudinal and irregularly shaped profiles were excluded from the analysis due to possibly higher perimeter/surface ratios and risk of biasing the silver grain counts towards the membrane. Any profiles containing large, irregularly shaped silver grains of more than 0.25 μm were excluded from the analysis. Cellular profiles that failed to meet any of the described criteria were excluded from analysis.

3. Results {#sec3}
==========

3.1. DGL-α protein expression is increased in male and female DβH-KO mice {#sec3.1}
-------------------------------------------------------------------------

To examine alterations of an eCB synthesizing enzyme under conditions of NE depletion, we measured DGL-α protein expression levels in the PFC of DβH-KO mice ([Fig. 1](#fig1){ref-type="fig"}). The effect of NE depletion and gender on DGL-α protein expression was analyzed using a two-way ANOVA, which revealed no significant effect for genotype (WT or DβH-KO) \[F~1,24~ = 2.8, p = 0.10\] or sex \[F~1,24~ = 0.98, p = 0.33\]. However, the interaction between factors was significant \[F~1,24~ = 16.33, p \< 0.0005\]. In WT mice, the average DGL-α protein expression for males was 0.62 ± 0.08 and for females was 0.21 ± 0.03. In DβH-KO mice, the average DGL-α protein expression for males was 0.88 ± 0.03 and for females was 0.69 ± 0.12. Tukey\'s post-hoc analysis following two-way ANOVA, as depicted in [Fig. 1](#fig1){ref-type="fig"}, showed that there were significant differences in DGL-α protein expression in the PFC between female WT and DβH-KO (p = 0.005), male WT and DβH-KO (p \< 0.05), and male WT and female WT (p \< 0.05). The significant differences in DGL-α protein expression between male WT and female WT indicate that there are initial baseline sex differences in DGL-α protein expression in the PFC in WT mice.Fig. 1Expression of Endocannabinoid-synthesizing Enzyme DGL-α in Prefrontal Cortex of wild-type (WT) and dopamine β-hydroxylase knockout (DβH-KO) male and female mice. **A.** Representative Western blot analysis shows DGL-α expression in cell lysates obtained from the PFC. **B.** DGL-α expression levels in PFC. Data are presented as mean ± SEM. Values with asterisks are significantly different (p \< 0.05) from each other. Male WT (n = 9), female WT (n = 6), male DβH-KO (n = 9), female DβH-KO (n = 6).Fig. 1

3.2. MGL and FAAH protein expression in DβH-KO mice {#sec3.2}
---------------------------------------------------

To examine alterations of eCB degrading enzymes under conditions of NE depletion, we measured MGL and FAAH protein expression levels in the PFC of DβH-KO mice ([Fig. 2](#fig2){ref-type="fig"}). In WT mice, average MGL protein expression in males was 0.64 ± 0.01 and in females was 0.71 ± 0.25. In DβH-KO mice, average MGL protein expression in males was 0.88 ± 0.16 and in females was 0.71 ± 0.25. Two-way ANOVA indicated no significant effects of sex (F~1,20~ = 2, p = 0.17), genotype (F~1,20~ = 2.4, p = 0.13), but a significant interaction between independent variables (F~1,20~ = 7.1, p = 0.015) on MGL protein expression. Tukey\'s post hoc analysis further identified the groups that were significantly different from each other as male WT compared to male DβH-KO (p = 0.037) and male DβH-KO compared to female DβH-KO (p = 0.04). In WT mice, average FAAH protein expression in males was 0.96 ± 0.04 and in females was 0.54 ± 0.02. In DβH-KO mice, average FAAH protein expression in males was 0.58 ± 0.09 and in females was 0.62 ± 0.15. Two-way ANOVA revealed significant effects of sex (F~1,20~ = 33, p \< 0.0001), genotype (F~1,20~ = 21, p = 0.0002), and an interaction between independent variables (F~1,20~ = 47, p \< 0.0001) in FAAH protein expression. Tukey\'s post hoc analysis further identified the groups that were significantly different from each other as male WT compared to male DβH-KO and male WT compared to female WT.Fig. 2Expression of Endocannabinoid-degrading Enzymes MGL, FAAH in Prefrontal Cortex of WT or DβH-KO Mice. **A.** Representative Western blot analysis shows MGL and FAAH expression. **B.** Quantification of MGL expression levels in PFC of WT or DβH-KO mice. **C.** Quantification of FAAH expression levels in PFC of WT or DβH-KO mice. Data are presented as mean ± SEM. Values with single or multiple asterisks are significantly different (p \< 0.05, p \< 0.0001, respectively) from each other. Tukey\'s multiple comparison test was run after two-way ANOVA. Male WT (n = 9), female WT (n = 6), male DβH-KO (n = 9), female DβH-KO (n = 6).Fig. 2

3.3. DGL-α expression is increased in male rats following DSP-4 exposure {#sec3.3}
------------------------------------------------------------------------

To characterize the effect of DSP-4 treatment in terms of NE tissue concentration, a NE ELISA was conducted on samples taken from saline-treated or DSP-4-treated male and female rats ([Fig. 3](#fig3){ref-type="fig"}C). NE levels in DSP-4-treated male and female rats (6.7 pg/mg ± 1.26) were significantly reduced (p \< 0.05) compared to saline treated rats (14.3 pg/mg ± 3.4) ([Fig. 3](#fig3){ref-type="fig"}C). DSP-4 injection resulted in a decrease to approximately 47% of normal NE tissue concentration in the PFC. To define alterations in the eCB system under conditions of NE depletion resulting from pharmacological lesion of the LC, we examined DGL-α protein expression in the PFC ([Fig. 3](#fig3){ref-type="fig"}) following DSP-4 injection. A significant increase in DGL-α in PFC was observed in DSP-4 male rats compared to the male saline control group (p \< 0.01). The effects of sex and treatment were analyzed using a two-way ANOVA, which revealed a significant effect of treatment (F~1,12~ = 6.2, p = 0.02) but not sex (F~1,12~ = 0.56, p = 0.47) or interaction (F~1,12~ = 0.124, p = 0.73). Post-hoc analysis revealed that DGL-α expression in male DSP-4 treated rats was significantly increased compared to male saline-treated controls (p = 0.002).Fig. 3Expression of Endocannabinoid-synthesizing Enzyme DGL-α in Prefrontal Cortex of Rats. DGL-α expression levels in the PFC of saline-and DSP-4-injected male and female rats. **A.** Representative Western blot analysis shows DGL-α expression in cell lysates obtained from the PFC. **B.** DGL-α expression levels in PFC. Data are presented as mean ± SEM. Values with asterisks are significantly different (p \< 0.05) from each other. Male saline (n = 6), male DSP-4 (n = 4), female saline (n = 3), female DSP-4 (n = 3). **C.** NE expression levels in PFC. Data are presented as mean ± SEM. Values with asterisks are significantly different (p \< 0.05) from each other. Saline (n = 6), DSP-4 (n = 6).Fig. 3

To investigate the possibility that there are significant differences in DGL-α levels at baseline, we also conducted Western blot analyses on PFC cell lysates of male and female naïve rats. Given the known influence of the estrous cycle in endogenous cannabinoid production, the female rats were subjected to daily vaginal smearing and were sacrificed during the proestrous phase. We examined DGL-α protein expression levels in the PFC of naïve male and female rats. There were no significant differences (p \> 0.05) in DGL-α protein expression levels between naïve male (0.72 ± 0.14) and female (0.5 ± 0.04) rats in the PFC.

3.4. MGL and FAAH are increased in the PFC of rats treated with DSP-4 {#sec3.4}
---------------------------------------------------------------------

To further examine alterations in eCB degrading enzymes under conditions of NE depletion, we examined MGL and FAAH protein expression levels in the PFC of saline- or DSP-4-treated rats ([Fig. 4](#fig4){ref-type="fig"}). In saline-treated rats, the average MGL protein expression for males was 0.32 ± 0.11 and for females was 0.55 ± 0.17. In DSP-4 treated rats, the average MGL protein expression for males was 0.68 ± 0.16 and for females was 0.58 ± 0.19. The effect of NE depletion and gender on MGL protein expression was analyzed using a two-way ANOVA, which revealed significant effects of treatment (F~1,22~ = 6.3, p = 0.02), but not sex (F~1,22~ = 0.26, p = 0.61), or interaction between independent variables (F~1,22~ = 3.8, p = 0.06). Tukey\'s post-hoc analysis following two-way ANOVA, as depicted in [Fig. 4](#fig4){ref-type="fig"}, showed that there were significant differences in MGL protein expression in the PFC between male saline- and DSP-4-treated rats (p \< 0.05).Fig. 4Expression of Endocannabinoid-metabolizing Enzymes MGL and FAAH in Prefrontal Cortex of Rats. **A.** Representative Western blot analysis shows DGL-α expression in cell lysates obtained from the PFC of saline- or DSP-4-treated rats. **B.** DGL-α expression levels in PFC of saline- or DSP-4-treated rats. **C.** Quantification of FAAH expression levels in PFC of saline- or DSP-4-treated rats. Data are presented as mean ± SEM. Values with asterisks are significantly different (p \< 0.05) from each other. Tukey\'s multiple comparison test was run after two-way ANOVA. Male WT (n = 9), female WT (n = 6), male DβH-KO (n = 9), female DβH-KO (n = 6).Fig. 4Fig. 5**A-D.** Confocal fluorescence photomicrographs showing immunolabeling of monoacylglycerol lipase (MGL), cannabinoid receptor type 1 (CB1r) and dopamine beta-hydroxylase (DβH) in the frontal cortex. MGL was detected using a fluorescein isothiocyanate (FITC) donkey anti-rabbit IgG (green); CB1r was detected using a tetramethylrhodamine-5-isothiocyanate (TRITC)-conjugated donkey anti-guinea pig IgG (red) and DβH was detected using a Cy5-conjugated donkey anti-mouse IgG (blue). CB1 and DβH appeared as punctate processes. The merged image (panel D) shows colocalization of MGL, CB1r and DβH in the same process (arrows). Arrowheads indicate single-labeled MGL, CB1r or DβH. Thick arrows indicate dual labeling (MGL and DβH or CB1r and DβH). **E-H.** Confocal fluorescence photomicrographs showing immunolabeling of MGL, CB1r and norepinephrine transporter (NET) in the frontal cortex. MGL was detected using a FITC donkey anti-rabbit IgG (green); CB1r was detected using a TRITC-conjugated donkey anti-guinea pig IgG (red) and NET was detected using a Cy5-conjugated donkey anti-mouse IgG (blue). CB1r and NET appeared as punctate processes. The merged image (panel H) shows colocalization of CB1 and NET in the same process (arrows) that is in close proximity with a MGL-labeled profile. Arrowheads indicate single-labeled MGL, CB1r or NET. Thick arrows indicate dual labeling (MGL and DβH or CB1 and DβH). Scale bars: 30 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 5Fig. 6**A-D.** Confocal fluorescence photomicrographs showing immunolabeling of fatty acid hydrolase (FAAH), CB1r and DβH in the frontal cortex. FAAH was detected using a FITC donkey anti-rabbit IgG (green); CB1r was detected using a TRITC-conjugated donkey anti-guinea pig IgG (red) and DβH was detected using a Cy5-conjugated donkey anti-mouse IgG (blue). CB1r and DβH appeared as punctate processes. The merged image (panel D) shows co-localization of CB1 and DβH in the same process (arrows) that is in close proximity with a FAAH-labeled profile (double arrowhead). **E-H.** Confocal fluorescence photomicrographs showing immunolabeling of FAAH, CB1r and norepinephrine transporter (NET) in the frontal cortex. FAAH was detected using a FITC donkey anti-rabbit IgG (green); CB1r was detected using a TRITC-conjugated donkey anti-guinea pig IgG (red) and NET was detected using a Cy5-conjugated donkey anti-mouse IgG (blue). CB1r and NET appeared as punctate processes. The merged image (panel H) shows co-localization of CB1 and NET in the same process (arrows) that is in close proximity with a FAAH-labeled profile (double arrowhead). Arrowheads indicate single-labeled FAAH, CB1r or NET. Thick arrows indicate dual labeling (FAAH and DβH or CB1 and DβH). Scale bars: 30 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 6Fig. 7Electron micrographs showing immunoperoxidase labeling for dopamine β-hydroxylase (DβH) in axon terminals and immunogold-silver labeling for monoacylglycerol lipase-α (MGL) in the prefrontal cortex. A. Immunoperoxidase labeling can be seen in a DβH-immunoreactive axon terminal (DβH-t) contacting (arrowheads) an unlabeled axon terminal. Also shown is an MGL-labeled terminal (MGL-t) that forms an asymmetric synapse (zigzag arrows) with an unlabeled dendrite (ud). B-F. Dense immunoperoxidase labeling can be seen in DβH-t that also contains MGL (DβH + MGL-t). DβH + MGL-t forms symmetric (arrowheads; Panels D and F), asymmetric (zigzag arrows; Panel C) or undefined (Panels B and E) synapse with ud. Arrows point to immunogold-silver labeling for MGL. ut: unlabeled terminal; Scale bars: 0.50 μm.Fig. 7Fig. 8Electron micrographs showing immunoperoxidase labeling for dopamine β-hydroxylase (DβH) in axon terminals and immunogold-silver labeling for fatty acid amide hydrolase (FAAH) in the prefrontal cortex. A-F. Dense immunoperoxidase labeling can be seen in a DβH-immunoreactive axon terminal (DβH-t) contacting a FAAH-labeled labeled dendrite (FAAH-d). A-B, D-E. DβH-t forms a symmetric synapse (arrowheads) with unlabeled dendrite (ud). C. A DβH-t that forms an asymmetric synapse (zigzag arrows) with a FAAH-d. F. A DβH-t forms undefined (curved arrow) synaptic contact with MGL-d. Arrows point to immunogold-silver labeling for MGL-α. ut: unlabeled terminal. Scale bars: 0.50 μm.Fig. 8

The effect of NE depletion and gender on FAAH protein expression was analyzed using a two-way ANOVA, which revealed significant effects of treatment (F~1,19~ = 18, p = 0.0005), sex (F~1,19~ = 18, p = 0.0004), and interaction between independent variables (F~1,19~ = 7.9, p = 0.01). In saline-treated rats, the average FAAH protein expression in males was 0.32 ± 0.11 and in females was 0.23 ± 0.06. In DSP-4 treated rats, the average FAAH protein expression in males was 0.72 ± 0.2 and in females was 0.31 ± 0.13. Post-hoc analysis following two-way ANOVA, as depicted in [Fig. 4](#fig4){ref-type="fig"}, showed that there were significant differences in FAAH protein expression in the PFC between male saline- and DSP-4-treated rats (p \< 0.05). There were also significant differences in male and female DSP-4-treated rats (p \< 0.05).

3.5. MGL or FAAH, CB1r and DβH or NET localization in the PFC {#sec3.5}
-------------------------------------------------------------

Using fluorescence microscopy, MGL ([Fig. 5](#fig5){ref-type="fig"}A, D) and FAAH ([Fig. 6](#fig6){ref-type="fig"}A, D) were visualized in the PFC. MGL immunoreactivity exhibited a punctate-like appearance while FAAH immunoreactivity was evident in the processes. Immunofluorescence labeling using three distinct fluorophore-tagged secondary antibodies to localize MGL or FAAH, CB1r and DβH or NET was conducted in the same section of tissue. Immunolabeling for MGL (green labeling; [Fig. 5](#fig5){ref-type="fig"}A,E), CB1r (red labeling; [Fig. 5](#fig5){ref-type="fig"}B,F), DβH (blue labeling; [Fig. 5](#fig5){ref-type="fig"}C) and NET (blue labeling; [Fig. 5](#fig5){ref-type="fig"}G) was distributed in the PFC. MGL is localized to CB1r- and DβH-containing processes ([Fig. 5](#fig5){ref-type="fig"}A--D) or CB1r- and NET-containing processes ([Fig. 5](#fig5){ref-type="fig"}E--H)). Immunolabeling for FAAH (green labeling; [Fig. 6](#fig6){ref-type="fig"}A,E), CB1r (red labeling; [Fig. 6](#fig6){ref-type="fig"}B,F), DβH (blue labeling; [Fig. 6](#fig6){ref-type="fig"}C) and NET (blue labeling; [Fig. 6](#fig6){ref-type="fig"}G) was distributed in the PFC. FAAH immunoreactivity was evident in the processes and is localized in close proximity to CB1r- and NET-containing processes ([Fig. 6](#fig6){ref-type="fig"}E--H) or CB1r- and DβH-containing processes ([Fig. 6](#fig6){ref-type="fig"}A--D). Consistent with our previous reports ([@bib66]; [@bib14]; [@bib75]), DβH was localized to processes that were highly varicose and punctate in appearance. It was observed that NET immunolabeling had similar morphology, consistent with our previous reports ([@bib14]; [@bib75]). To further define substrates for putative interactions between MGL or FAAH and DβH, putative associations were analyzed using immunoelectron microscopy.

3.6. Ultrastructural analysis of MGL and DβH in the PFC {#sec3.6}
-------------------------------------------------------

Immunoperoxidase labeling for DβH and immunogold-silver labeling for MGL were localized in the same section of tissue in the area of interest sampled for semi-quantitative analysis ([Fig. 7](#fig7){ref-type="fig"}A--F). MGL immunogold-silver labeling was clearly distinguishable from the immunoperoxidase labeling of DβH. The area that was sampled in the PFC for electron microscopy was the same as that shown in [Fig. 5](#fig5){ref-type="fig"} for immunofluorescence microscopy ([Fig. 5](#fig5){ref-type="fig"}, A, D). As previously demonstrated ([@bib66]; [@bib75]), the immunoperoxidase labeling for DβH could be identified as an electron dense reaction product localized within vesicle-filled axon terminals ([Fig. 7](#fig7){ref-type="fig"}A--F). As previously reported by other groups ([@bib117]; [@bib112]) and our group ([@bib66]; [@bib75]) the majority of the DβH-containing profiles was observed in unmyelinated axons and varicosities. MGL immunoreactivity detected by immunogold-silver labeling, similar to DβH, was localized primarily in the unmyelinated axons and varicosities. Immunogold-silver labeling for MGL appeared as black deposits that were distributed along the plasma membrane ([Fig. 7](#fig7){ref-type="fig"}B, D, E) and within the cytoplasmic compartment ([Fig. 7](#fig7){ref-type="fig"}A, C, D).

3.7. Ultrastructural analysis of FAAH and DβH in the PFC {#sec3.7}
--------------------------------------------------------

Immunoperoxidase labeling for DβH and immunogold-silver labeling for FAAH were localized in the same section of tissue in the area of interest sampled for semi-quantitative analysis ([Fig. 8](#fig8){ref-type="fig"}). FAAH immunogold-silver labeling was clearly distinguishable from the immunoperoxidase labeling indicative of DβH. While the majority of DβH-containing profiles was localized in unmyelinated axons and varicosities, FAAH immunoreactivity was detected primarily in dendritic processes ([Fig. 8](#fig8){ref-type="fig"}). Clearly, DβH-containing axon terminals target FAAH-containing dendrites ([Fig. 8](#fig8){ref-type="fig"}), thus DβH labeling at the ultrastructural level was presynaptically localized with respect to FAAH-containing dendrites ([Fig. 8](#fig8){ref-type="fig"}). Targets of DβH-containing axon terminals ranged from small to large and longitudinal dendritic processes.

4. Discussion {#sec4}
=============

Here, we examined functional and anatomical endpoints of DGL-α, MGL and FAAH that differentially act within the eCB system as they respond to circumstances in which the noradrenergic system is dysregulated. Our findings reveal interesting sex differences in adaptations to noradrenergic depletion ([Table 1](#tbl1){ref-type="table"}). In DβH-KO mice there is a global depletion of NE from birth that results in increased expression of the 2-AG synthesizing enzyme, DGL-α, in both males and females. Coupled with the finding that there was no significant change in expression of the 2-AG degrading enzyme, MGL, there may be an increase in 2-AG in the PFC of male and female DβH-KO mice, however future studies utilizing high performance liquid chromatography paired with mass spectrometry would be necessary to confirm this observation. We observed sex differences in the expression of the AEA degrading enzyme, FAAH, such that FAAH expression decreased in DβH-KO male mice and did not change in DβH-KO female mice. Taken together, these results suggest a possible increase in eCB tone of both sexes.Table 1Summary of alterations in eCB system resulting from NE depletion. Arrows with asterisks denotes significant alterations determined by ANOVA (p \< 0.05), while arrow alone represents a trend that is not statistically significant.Table 1KO MaleKO FemaleDSP-4 MaleDSP-4 FemaleDGL-α↑\*↑\*↑\*↑MGLNo ChangeNo Change↑\*No ChangeFAAH↑\*No Change↑\*No Change

DSP-4-treated rats that suffer postnatal noradrenergic loss show distinct eCB changes between sexes. Male rats treated with DSP-4 may have an increase in eCB turnover, resulting from increased expression of the 2-AG-synthesizing enzyme DGL-α, as well as increased expression of the 2-AG- and AEA-degrading enzymes MGL and FAAH, respectively. Meanwhile, female rats treated with DSP-4 show no differences in DGL-α, MGL or FAAH. Given that female DβH-KO mice exhibit changes in the level of DGL-α, this could indicate that compensatory mechanisms for postnatal NE depletion are different between sexes, or that males are more eCB responsive than females to NE depletion. Compensatory responses have been described for LC neurons that survive DSP-4 lesion. These neurons attempt to restore NE tone in projection regions by increasing firing rate ([@bib34]). Thus, a selective increase in firing of remaining NE neurons in the PFC in female rats could explain the lack of eCB system changes.

The functional data we report in rats treated with DSP-4 are further supported with our anatomical data in naïve rats. Corroborating the reports of others, here we show that the 2-AG-degrading enzyme MGL is localized presynaptically, and more specifically, on terminals that also exhibit DβH, the NE synthesizing enzyme or NET. Previous reports utilized northern blot and in situ hybridization to characterize the distribution of MGL mRNA transcripts in the cortex, identifying the highest concentrations in layers IV, V and VI ([@bib30]; [@bib40]).We previously reported anatomical evidence indicating that DGL-α is localized postsynaptically, and this is consistent with the putative retrograde signaling of 2-AG that is initiated at the postsynaptic site by DGL-α and terminated at the presynaptic site by MGL following CB1r activation. In contrast to 2-AG, AEA is thought to act as an autocrine signaling molecule to regulate tonic eCB signaling. Our functional and anatomical data indicate that in naïve rats, the AEA-degrading enzyme, FAAH, is localized postsynaptically to DBH or NET containing axon terminals. These observations are in line with previously published ultrastructural studies on the subcellular localization of FAAH that focused on the hippocampus, cerebellum and amygdala which identify post-synaptic compartments and cytoplasmic membranes such as the mitochondria and smooth endoplasmic reticulum known to store Ca2+ as a primary site of FAAH localization ([@bib40]). In support of these findings, [Fig. 8](#fig8){ref-type="fig"} panel B-C and E display examples of FAAH immunolabeling that appears tethered to cytosolic membranes of the mitochondria. This anatomical evidence is consistent with the notion that Ca2+ release dictates, at least in part, the synthesis and release of eCBs and their degradation ([@bib40]).

4.1. Functional implications {#sec4.1}
----------------------------

The results of our DSP-4-lesion studies confirm that NE depletion results in increased production of eCB markers, and are in line with the results of DβH-KO mouse models. These studies highlight the complexity of interplay between the NE and eCB systems, demonstrating that various degrees of noradrenergic depletion recruit specific elements of the eCB system, despite vastly different modes of disrupting LC functioning. These findings may have important implications for clinical conditions where the LC-NE system is thought to be perturbed, such as in the stress-related psychiatric disorders of anxiety and depression, and neurodegenerative conditions such as AD and multiple sclerosis ([@bib37]; [@bib54]; [@bib86]; [@bib56]; [@bib11]; [@bib61]; [@bib58]). The LC-NE system is engaged in parallel with the peripheral stress response when corticotropin releasing factor (CRF) is released onto the LC, resulting in the excitation of the soma and subsequent synthesis and release of NE at the many projection sites throughout the neuraxis ([@bib98]). HPA-axis hyperactivity, downstream of CRF input, is thought to play a critical role in the etiology of stress related psychiatric disorders ([@bib101]; [@bib76]; [@bib98]). Thus, systems that counteract responsivity to stress, such as the eCB system, may be important avenues of investigation to treat stress-related psychiatric disorders.

The eCB system may be a particularly advantageous target for such disorders because it is poised to counteract stress-responsivity in a spatially and temporally distinct manner ([@bib115]). Spatially, previous anatomical studies have noted that MGL and FAAH distributions are tightly overlapping with areas containing a high density of CB1r ([@bib30]). CB1 receptors are localized pre-and post-synaptically in the LC. Of particular importance are the presynaptic CB1 receptors on glutamatergic terminals, whose activation may restrain the release of excitatory amino acid neurotransmitters onto LC neurons. In LC, CB1 is expressed postsynaptically on LC-NE neurons ([@bib83]) as well as presynaptically including on glutamate terminals. CB1 is thus anatomically positioned to regulate glutamatergic drive to LC neurons, restraining their activity([@bib60]). Additionally, AEA acts in a spatially and temporally specific manner in that it is released tonically to restrain HPA activity in the amygdala. To initiate the stress response, AEA in the amygdala is decreased following an increase in FAAH expression levels. This results in disinhibition of excitatory afferents projecting to the hypothalamus, therefore allowing the transmission of ACTH and CRF. This response is later terminated when glucocorticoids are released into the amygdala and mediate an increase in AEA levels, thereby restoring HPA axis restraint, and preventing excessive stimulation of the stress circuit ([@bib41]). Thus, therapeutic approaches that harness the endogenous spatial organization and temporal responses of the eCB system, for example, FAAH or MGL inhibitors, may be particularly effective at treating stress-related psychiatric disorders.

### 4.1.1. Sex differences {#sec4.1.1}

Recent studies have found that the LC-NE arousal axis has sex differences in signaling and trafficking, particularly for corticotropin-releasing factor receptor 1 (CRFR1), that mediates stress responses ([@bib76]; [@bib97]; [@bib96]). CRFR1 signaling and trafficking could contribute to the sex differences observed in the eCB system during NE dysregulation and should be further investigated. Much of the preclinical support for this is founded on morphological ([@bib4]), cellular ([@bib3]), and biochemical ([@bib96]) sex differences at the CRF-LC synapse in response to stress, rendering females more responsive to prolonged stress. It is interesting to consider that male resilience to stress-related psychiatric disorders, at least in part, may be derived from the prominent role of the eCB system in males, whereas females lack the same eCB tone and responsiveness. This may allude to sexually divergent approaches to treating stress-related psychiatric disorders, as enhancing eCB tone may be more effective in alleviating stress in male, however females have stronger response to exogenous cannabinoid administration; thus, further investigation is required ([@bib6]; [@bib8]; [@bib9]; [@bib7]).

The finding that male DβH-KO mice and male rats treated with DSP-4 are more eCB responsive compared to females is consistent with our previous findings, as well as the findings of other laboratories that have investigated sex differences in the eCB system. In a recent whole-cell patch-clamp electrophysiology study conducted on LC brain sections taken from mice lacking the CB1r (CB1r-KO), it was demonstrated that male CB1r-KO mice had heightened LC-NE activity compared to female CB1r-KO mice and to WT mice. This was evident as increased NE cell excitability in male CB1r KOs, whereas there were no significant changes in CB1r-KO females ([@bib108]). Further support for the sex differences observed in this study were corroborated by NE ELISA, in which there was increased NE in CB1r-KO males compared to CB1r-KO females and WT controls ([@bib108]). Additionally, other studies examining mice of both sexes that are CB1r-KO, or that are WT with the administration of CB1r antagonists, demonstrate that females do not show hypothalamic-pituitary-adrenal (HPA) axis hyper-reactivity to the same degree as males ([@bib2]; [@bib77]). Thus, the LC-NE system of females would also likely be less responsive to CB1r deletion considering that this system is activated by the HPA axis. Our studies support this rationale as we demonstrate that alterations to the noradrenergic system result in reciprocal alterations in the endocannabinoid system that are more dramatic in males compared to females.

### 4.1.2. Methodological considerations {#sec4.1.2}

Western blot analysis was conducted in parallel with ELISA studies to determine protein expression levels of the NE synthesizing enzyme, DβH, in these animals. These results were recently reported, and indicate that DβH protein expression in DSP-4-treated animals was significantly reduced compared to saline and naïve rats ([@bib78]). It is possible that the effects of NE depletion on the eCB system in the PFC are indirect. Constitutive genetic deletion of DβH may produce adaptations during development that subsequently have effects on the eCB system ([@bib93]). Further, genetic deletion and DSP-4 treatment both cause systemic effects that could impact PFC function indirectly.

While DSP-4 primarily affects LC neurons, it also affects regions strongly innervated by LC neurons, such as hippocampus and dorsal raphe ([@bib79]; [@bib80]; [@bib81]). Indeed, DSP-4 is widely used in the literature as a central noradrenergic system lesion and its implications in other circuitries, such as opioid and dopaminergic circuits, as well as related noradrenergic circuits ([@bib120]; [@bib113], [@bib114]). A DSP-4 induced lesion provides insight into NE deficits even in these broader scenarios, due to the relative breadth of action of DSP-4. More specific mechanisms for further corroboration could be undertaken, such as investigating active noradrenergic neurons of the LC. One such mechanism would be DβH conjugated with saporin, which provide a more complete lesion compared to DSP-4. Saporin has been used this way in other studies ([@bib14]; [@bib118]; [@bib111]), and works by binding a targeted receptor, becoming internalized, and subsequently causes downstream cell death.

5. Conclusions {#sec5}
==============

Anatomical and physiological studies have confirmed the critical involvement of eCBs in a variety of physiological and pathological processes including emotional reactivity, motivated behaviors and energy homeostasis ([@bib33]; [@bib35]; [@bib49]; [@bib57]; [@bib46]; [@bib16],[@bib17]; [@bib45]; [@bib92]; [@bib19]; [@bib107]). Our data support the hypothesis that the NE and eCB systems are intricately connected. Previous studies have demonstrated the consequences of altering eCB signaling on the LC-NE system. In the present study we aimed to determine the effects of NE depletion on the eCB system. These data add to the accumulating evidence that dysregulation of NE transmission leads to significant alterations in the eCB system, which may have profound implications for neurological and psychiatric disorders. Further investigations will help to understand the relationship of eCB regulation and the NE system in the brain and may lead to new approaches in research for potential more targeted medical applications of cannabinoids in the treatment of neurological and psychiatric disorders in the future.
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